HIGH · 8.8

CVE-2026-5781

An authorization vulnerability in MphRx's Minerva V3.6.0, specifically in the '/minerva/moUser/update' endpoint, could allow an authenticated user with user modification privileges to escalate their p...

Vulnerability Description

An authorization vulnerability in MphRx's Minerva V3.6.0, specifically in the '/minerva/moUser/update' endpoint, could allow an authenticated user with user modification privileges to escalate their privileges by sending an HTTP request with a manipulated 'identifier' field. Successful exploitation of this vulnerability could allow an authenticated user to obtain administrator privileges. It is not possible to escalate privileges through the graphical user interface.

CVSS Score

8.8

HIGH

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
NONE
Scope
UNCHANGED
Confidentiality
HIGH
Integrity
HIGH
Availability
HIGH

Affected Products

VendorProductVersions
AgilonhealthMinerva3.6.0

Related Weaknesses (CWE)

References

FAQ

What is CVE-2026-5781?

CVE-2026-5781 is a vulnerability with a CVSS score of 8.8 (HIGH). An authorization vulnerability in MphRx's Minerva V3.6.0, specifically in the '/minerva/moUser/update' endpoint, could allow an authenticated user with user modification privileges to escalate their p...

How severe is CVE-2026-5781?

CVE-2026-5781 has been rated HIGH with a CVSS base score of 8.8/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2026-5781?

Check the references section above for vendor advisories and patch information. Affected products include: Agilonhealth Minerva.